• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2007 Fiscal Year Final Research Report Summary

Study on the mechanism of rhabdomyosis induced by statins and gene analysis of patients with rhalxiomyasis

Research Project

Project/Area Number 18590525
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Laboratory medicine
Research InstitutionGifu University

Principal Investigator

TAKEMURA Masao  Gifu University, Graduate School of Medicine, Assistant Professor (80402155)

Co-Investigator(Kenkyū-buntansha) SEISHIMA Mitsuru  Gifu University, Graduate School of Medicine, Professor (10171315)
SAITO Kuniaki  Gifu University, Graduate School of Medicine, Part-time Lecturer (80262765)
Project Period (FY) 2006 – 2007
Keywordshyperlipidemia / statin drugs / rhabdomvosis
Research Abstract

TO investigate the mechanism of rhabdomyosis induced by statin drugs, we confirmed the expression of Ryanodine receptor type 1 (RyR1), which is a responsible gene for malignant hyperthermia, in human peripheral blood mononuclear cells (PBMC). We also determined the increment of calcium concentration in PBMC when various statins were added. Rosuvastatin, Simvastatin, Fluvastatin and Cerivastatin increased CO- in PBMC, but Pravastatin did not Since Rosuvastatin increased Ca2+ most, we used Rosuvastatin in further in vitro study Rosuvastatin was added on PBMC in patients treated with statins The increment of Cats- in PMBC was significantly increased in 15 patients with high serum CK level compared to 5 patients with normal CK level. (P<0.0001), but there was no difference in Ca^(2+) increment between 45 healthy controls and 5 patients with normal CK The increment of Cd^(2+) in PMBC by the addition of statins is considered to be derived from SKR and mitochondria. In addition, we investigated the effect of Xestospongin C, an thibitor of 1P3 receptor, but we could not determine the origin of Ca^(2+) release, IP3 receptor or RyR. We analyzed genotype of RyR in patients with high CK, but we could not find any RyR mutations.
In conclusion, it is useful to determine Ca^(2+) concentration in PBMC stimulated by statins for the elimination of side effect such as rhabdomyosis caused by statins.

  • Research Products

    (12 results)

All 2008 2007

All Presentation (12 results)

  • [Presentation] スタチン製剤による末梢血単核細胞に対するCa2+放出効果2008

    • Author(s)
      服部高幸, 他
    • Organizer
      第47回日本臨床検査医学会東海北陸支部総会
    • Place of Presentation
      富山市
    • Year and Date
      2008-03-09
    • Description
      「研究成果報告書概要(和文)」より
  • [Presentation] Ca^<2+> rdeasee in PBMC by statin drugs2008

    • Author(s)
      Hattori, Takayuki
    • Organizer
      47th Tokai-Hokuriku District Conference in Japanese Society of Clinical Pathology
    • Place of Presentation
      Toyama City
    • Year and Date
      2008-03-09
    • Description
      「研究成果報告書概要(欧文)」より
  • [Presentation] 脂肪肝患者におけるアポB48の測定2007

    • Author(s)
      古田伸行, 他
    • Organizer
      第54回日本臨床検査医学会総会
    • Place of Presentation
      大阪市
    • Year and Date
      20071122-25
    • Description
      「研究成果報告書概要(和文)」より
  • [Presentation] NASH患者血中のCytokeratin-18測定の臨床的意義について2007

    • Author(s)
      服部高幸, 他
    • Organizer
      第54回日本臨床検査医学会総会
    • Place of Presentation
      大阪市
    • Year and Date
      20071122-25
    • Description
      「研究成果報告書概要(和文)」より
  • [Presentation] Apo B48 determination in patients with fatty liver2007

    • Author(s)
      Furuta, Nobuyuki
    • Organizer
      54th Conference of Japane : e Scciety of Clinical Pathalogy
    • Place of Presentation
      Osaka City
    • Year and Date
      20071122-25
    • Description
      「研究成果報告書概要(欧文)」より
  • [Presentation] Clinical signifraneen of Cytokeratin-18 determination in patients with NASH2007

    • Author(s)
      Hattori, Takayuki
    • Organizer
      54th Conference in Japanese Society of Clinical Pathology
    • Place of Presentation
      Osaka City
    • Year and Date
      20071122-25
    • Description
      「研究成果報告書概要(欧文)」より
  • [Presentation] 小児における脂肪肝とメタポリックシンドロームの関連性について2007

    • Author(s)
      林 恭子, 他
    • Organizer
      第32回日本超音波検査学会
    • Place of Presentation
      東京
    • Year and Date
      2007-05-13
    • Description
      「研究成果報告書概要(和文)」より
  • [Presentation] 小児メタボリックシンドロームと肝機能障害について2007

    • Author(s)
      渡辺恒夫, 他
    • Organizer
      第32回日本超音波検査学会
    • Place of Presentation
      東京
    • Year and Date
      2007-05-13
    • Description
      「研究成果報告書概要(和文)」より
  • [Presentation] The relationship between fatty liver and metabolic syndrome in the child2007

    • Author(s)
      Hayashi, kyouko
    • Organizer
      32th Conference of Japan Ultrasonograph
    • Place of Presentation
      Tokyo
    • Year and Date
      2007-05-13
    • Description
      「研究成果報告書概要(欧文)」より
  • [Presentation] Liver dysfunction in child metabolic syndrome2007

    • Author(s)
      Watanabe, Tsuneo
    • Organizer
      32th Conference of JapanUltrasonograph
    • Place of Presentation
      Tokyo
    • Year and Date
      2007-05-13
    • Description
      「研究成果報告書概要(欧文)」より
  • [Presentation] Clinical significance of the determination of high Molecular adiponectin in patients with fatty liver2007

    • Author(s)
      Hat6tori, Takayuki
    • Organizer
      46th Tokai-Hokuriku District Conference in Society of Clinical Pathology
    • Place of Presentation
      Tsu City
    • Year and Date
      2007-05-03
    • Description
      「研究成果報告書概要(欧文)」より
  • [Presentation] 脂肪肝患者における高分子量アディポネクチン測定の臨床的意義2007

    • Author(s)
      服部高幸, 他
    • Organizer
      第46回日本臨床検査医学会東海北陸支部総会
    • Place of Presentation
      津市
    • Year and Date
      2007-03-03
    • Description
      「研究成果報告書概要(和文)」より

URL: 

Published: 2010-02-04  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi